文献速递腹部泌尿生殖技术与安全CTMRPET

解码基因:腹部选择性恶性肿瘤影像基因组学最新进展

Decoding Genes: Current Update on Radiogenomics of Select Abdominal Malignancies.
PubMed 文献 · Radiographics · 2020-01-01

本文综述了影像基因组学在腹部恶性肿瘤中的应用,旨在将影像特征与基因突变及表达模式相关联,提供可替代基因检测的影像生物标志物,用于预测治疗反应和预后并指导个体化治疗。多排CT、多参数MRI及多示踪剂PET常用于评估影像基因组学关联,多种腹部恶性肿瘤具有与基因突变相对应的特征性影像表现。

要点

  • 影像基因组学将影像特征与基因突变及表达模式关联,可能提供替代基因检测的影像生物标志物。
  • 多排CT、多参数MRI及多示踪剂PET是评估影像基因组学关联的常用技术。
  • 部分腹部恶性肿瘤的侵袭性表型相关突变可依据其影像特征进行预测。

核心结论

  • 影像基因组学可提供替代基因检测的影像生物标志物,用于预测治疗反应和预后并指导个体化治疗。
  • 部分腹部恶性肿瘤的侵袭性表型相关突变有时可依据其影像特征进行预测。
  • 放射科医生应熟悉具有影像生物标志物的常见癌症的遗传学和发病机制,以成为癌症管理团队的重要成员并指导临床医生和病理医生。

研究设计与样本

  • 本文为综述,检索范围与纳入文献原文未报告。

关键影像表现/征象

  • 脂肪性和非脂肪性肝腺瘤、肝恶性肿瘤的多种形态-分子亚型、多种透明细胞和非透明细胞肾细胞癌、胰腺多种遗传性和散发性外分泌及神经内分泌肿瘤具有特征性影像表现,与基因突变相对应。
  • 胃肠道间质瘤基于特征性KIT基因突变已开发出靶向治疗药物。

诊断标准与关键数值

  • 原文未报告具体的敏感度、特异度、AUC、阈值或分级标准。

临床应用与阅片要点

  • 放射科医生应熟悉具有影像生物标志物的常见癌症的遗传学和发病机制,以指导临床医生和病理医生。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Technologic advances in chromosomal analysis and DNA sequencing have enabled genome-wide analysis of cancer cells, yielding considerable data on the genetic basis of malignancies. Evolving knowledge of tumor genetics and oncologic pathways has led to a better understanding of histopathologic features, tumor classification, tumor biologic characteristics, and imaging findings and discovery of targeted therapeutic agents. Radiogenomics is a rapidly evolving field of imaging research aimed at correlating imaging features with gene mutations and gene expression patterns, and it may provide surrogate imaging biomarkers that may supplant genetic tests and be used to predict treatment response and prognosis and guide personalized treatment options. Multidetector CT, multiparametric MRI, and PET with use of multiple radiotracers are some of the imaging techniques commonly used to assess radiogenomic associations. Select abdominal malignancies demonstrate characteristic imaging features that correspond to gene mutations. Recent advances have enabled us to understand the genetics of steatotic and nonsteatotic hepatocellular adenomas, a plethora of morphologic-molecular subtypes of hepatic malignancies, a variety of clear cell and non-clear cell renal cell carcinomas, a myriad of hereditary and sporadic exocrine and neuroendocrine tumors of the pancreas, and the development of targeted therapeutic agents for gastrointestinal stromal tumors based on characteristic KIT gene mutations. Mutations associated with aggressive phenotypes of these malignancies can sometimes be predicted on the basis of their imaging characteristics. Radiologists should be familiar with the genetics and pathogenesis of common cancers that have associated imaging biomarkers, which can help them be integral members of the cancer management team and guide clinicians and pathologists. Online supplemental material is available for this article. ©RSNA, 2020 See discussion on this article by Luna (pp 1627-1630).

来源:Radiographics,查看原文。版权归原作者所有。

引用

  1. Katabathina VS, Marji H, Khanna L, et al. Decoding Genes: Current Update on Radiogenomics of Select Abdominal Malignancies. Radiographics. 2020. PMID: 33001791. doi:10.1148/rg.2020200042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。